Cargando…
T Cells as an Emerging Target for Chronic Pain Therapy
The immune system is critically involved in the development and maintenance of chronic pain. However, T cells, one of the main regulators of the immune response, have only recently become a focus of investigations on chronic pain pathophysiology. Emerging clinical data suggest that patients with chr...
Autores principales: | Laumet, Geoffroy, Ma, Jiacheng, Robison, Alfred J., Kumari, Susmita, Heijnen, Cobi J., Kavelaars, Annemieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749081/ https://www.ncbi.nlm.nih.gov/pubmed/31572125 http://dx.doi.org/10.3389/fnmol.2019.00216 |
Ejemplares similares
-
CD3(+) T cells are critical for the resolution of comorbid inflammatory pain and depression-like behavior
por: Laumet, Geoffroy, et al.
Publicado: (2020) -
CD8(+) T cell–derived IL-13 increases macrophage IL-10 to resolve neuropathic pain
por: Singh, Susmita K., et al.
Publicado: (2022) -
Inhibition of Mitochondrial p53 Accumulation by PFT-μ Prevents Cisplatin-Induced Peripheral Neuropathy
por: Maj, Magdalena A., et al.
Publicado: (2017) -
Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment
por: Ma, Jiacheng, et al.
Publicado: (2018) -
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice
por: Zhou, Wenjun, et al.
Publicado: (2016)